Stock 603939 YIFENG PHARMACY CHAIN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Yifeng Pharmacy Chain Co., Ltd.

Equities

603939

CNE100001TS5

Drug Retailers

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
22.65 CNY -0.66% Intraday chart for Yifeng Pharmacy Chain Co., Ltd. -7.06% -32.12%
Apr. 28 Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 25 Yifeng Pharmacy Chain Lists 1.80 Billion Yuan Worth of Convertible Bonds on Shanghai Bourse MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,745 47,897 39,611 46,074 40,464 27,462 - -
Enterprise Value (EV) 1 27,132 46,953 37,992 43,468 38,490 23,207 20,761 20,989
P/E ratio 50.8 x 62 x 44.4 x 36.3 x 28.6 x 15.7 x 13 x 10.5 x
Yield 0.41% 0.33% 0.54% 0.63% 1.25% 2.12% 2.55% 3.07%
Capitalization / Revenue 2.7 x 3.64 x 2.58 x 2.32 x 1.79 x 1.01 x 0.83 x 0.69 x
EV / Revenue 2.64 x 3.57 x 2.48 x 2.19 x 1.7 x 0.85 x 0.63 x 0.52 x
EV / EBITDA 27 x 34.1 x 23.7 x 19.6 x 15.7 x 7.53 x 5.69 x 4.79 x
EV / FCF 53 x - - - 9.87 x 12.7 x 6.63 x 5.06 x
FCF Yield 1.89% - - - 10.1% 7.87% 15.1% 19.8%
Price to Book 6.15 x 9.13 x 5.29 x 5.38 x 4.13 x 2.47 x 2.15 x 1.87 x
Nbr of stocks (in thousands) 1,158,593 1,159,853 1,207,526 1,212,464 1,212,696 1,212,453 - -
Reference price 2 23.95 41.30 32.80 38.00 33.37 22.65 22.65 22.65
Announcement Date 4/8/20 4/27/21 4/28/22 4/27/23 4/28/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 10,276 13,145 15,326 19,886 22,588 27,241 32,929 40,049
EBITDA 1 1,006 1,379 1,600 2,218 2,456 3,080 3,649 4,378
EBIT 1 815.5 1,170 1,339 1,886 2,055 2,596 3,149 3,920
Operating Margin 7.94% 8.9% 8.74% 9.48% 9.1% 9.53% 9.56% 9.79%
Earnings before Tax (EBT) 1 814.3 1,164 1,338 1,877 2,038 2,566 3,114 3,894
Net income 1 543.8 768.3 887.9 1,266 1,412 1,766 2,142 2,676
Net margin 5.29% 5.84% 5.79% 6.36% 6.25% 6.48% 6.51% 6.68%
EPS 2 0.4716 0.6662 0.7381 1.048 1.167 1.444 1.748 2.165
Free Cash Flow 1 511.4 - - - 3,900 1,827 3,130 4,148
FCF margin 4.98% - - - 17.26% 6.71% 9.51% 10.36%
FCF Conversion (EBITDA) 50.84% - - - 158.76% 59.3% 85.79% 94.75%
FCF Conversion (Net income) 94.06% - - - 276.18% 103.45% 146.12% 154.99%
Dividend per Share 2 0.0981 0.1374 0.1786 0.2381 0.4167 0.4807 0.5775 0.6961
Announcement Date 4/8/20 4/27/21 4/28/22 4/27/23 4/28/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,388 4,148 4,602 4,598 6,539 5,266 5,441 - 5,181 6,700 5,971 6,511 6,321 7,845 7,609 8,023
EBITDA 299.4 481.4 - - - - - - - - - - - - - -
EBIT 1 307.2 407.3 443.1 366.9 668.2 501.7 531.1 - 436.1 586 593.5 661.7 582.4 638.7 727.2 817.8
Operating Margin 7% 9.82% 9.63% 7.98% 10.22% 9.53% 9.76% - 8.42% 8.75% 9.94% 10.16% 9.21% 8.14% 9.56% 10.19%
Earnings before Tax (EBT) 1 306.2 407.3 446 366.5 657.8 500.8 530.9 1,032 436.1 569.8 593.2 645.9 633 711.5 763.5 829.9
Net income 1 191.9 272.2 304.2 247.2 442 336.5 368.7 705.2 294 412.8 406.8 447.6 438.6 497.4 529.1 575.1
Net margin 4.37% 6.56% 6.61% 5.38% 6.76% 6.39% 6.78% - 5.67% 6.16% 6.81% 6.87% 6.94% 6.34% 6.95% 7.17%
EPS 2 0.1607 0.2262 0.2500 0.2024 0.3690 0.2798 0.3036 - 0.2417 0.3417 0.3333 0.3730 0.3372 0.4600 0.3821 0.4071
Dividend per Share 2 - - - - - - - - - - - 0.4167 - - - 0.5283
Announcement Date 4/28/22 4/28/22 8/29/22 10/28/22 4/27/23 4/27/23 8/29/23 8/29/23 10/30/23 4/28/24 4/28/24 - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 613 945 1,619 2,606 1,974 4,255 6,701 6,473
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 511 - - - 3,900 1,827 3,130 4,148
ROE (net income / shareholders' equity) 12.7% 15.5% 13% 15.8% 15.4% 16.3% 17.5% 19%
ROA (Net income/ Total Assets) 6.38% 6.95% 5.48% - 6.25% 7.22% 7.61% 8.1%
Assets 1 8,521 11,062 16,190 - 22,592 24,442 28,148 33,051
Book Value Per Share 2 3.890 4.530 6.200 7.060 8.080 9.180 10.50 12.10
Cash Flow per Share 2 0.8300 1.150 1.780 3.230 3.810 2.600 2.990 3.420
Capex 1 452 579 821 578 724 1,483 1,414 1,181
Capex / Sales 4.4% 4.4% 5.36% 2.91% 3.21% 5.45% 4.29% 2.95%
Announcement Date 4/8/20 4/27/21 4/28/22 4/27/23 4/28/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Yifeng Pharmacy Chain Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
22.65 CNY
Average target price
43.7 CNY
Spread / Average Target
+92.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-32.12% 3.81B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-55.19% 9.93B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-47.06% 9.29B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-26.42% 6.82B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-3.26% 6.45B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+97.00% 5.26B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.48% 4.62B
CLICKS GROUP LIMITED Stock Clicks Group Limited
+8.08% 4.56B
REDCARE PHARMACY NV Stock Redcare Pharmacy NV
+6.99% 3.06B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-22.93% 2.55B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 603939 Stock
  4. Financials Yifeng Pharmacy Chain Co., Ltd.